Steven B. Sands

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Hans Rollema, Leslie K. Chambers, J.W. Coe et al. · Neuropharmacology · 2006 · 535 citations

Public Health, Pharmacology, Pharmacotherapy +14

Discovery of<i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia:  Synthesis and Structure−Activity Relationship

Donn G. Wishka, Daniel P. Walker, Karen M. Yates et al. · Journal of Medicinal Chemistry · 2006 · 190 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes.

Steven B. Sands, Richard S. Lewis, Michael D. Cahalan · The Journal of General Physiology · 1989 · 154 citations · Full text

Life Sciences, Biophysics, Immunology +17

Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes

Steven B. Sands, Ana Catarina Costa, Jim Patrick · Biophysical Journal · 1993 · 91 citations · Full text

Life Sciences, Neurobiology, Neuroscience +11